BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31055563)

  • 1. The role of interleukins and their inhibitors in the development of autoimmune uveitis.
    Kuryltsiv NB; Halei KM
    Wiad Lek; 2019; 72(4):716-722. PubMed ID: 31055563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic agents in experimental autoimmune uveitis.
    Giuliari GP; Sadaka A; Hinkle DM
    Int Ophthalmol; 2014 Feb; 34(1):145-56. PubMed ID: 23494482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features.
    Prete M; Dammacco R; Fatone MC; Racanelli V
    Clin Exp Med; 2016 May; 16(2):125-36. PubMed ID: 25820692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU).
    Sun D; Liang D; Kaplan HJ; Shao H
    Cytokine; 2015 Jul; 74(1):76-80. PubMed ID: 25742774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular inflammation in autoimmune diseases.
    Pras E; Neumann R; Zandman-Goddard G; Levy Y; Assia EI; Shoenfeld Y; Langevitz P
    Semin Arthritis Rheum; 2004 Dec; 34(3):602-9. PubMed ID: 15609264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of cytokines in ocular inflammation].
    Rusiecka-Ziółkowska J; Misiuk-Hojło M
    Przegl Lek; 1997; 54(12):863-6. PubMed ID: 9591456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in uveitis.
    Weinstein JE; Pepple KL
    Curr Opin Ophthalmol; 2018 May; 29(3):267-274. PubMed ID: 29521875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-21 and tumor necrosis factor-α are critical for the development of autoimmune gastritis in mice.
    Nishiura H; Iwamoto S; Kido M; Aoki N; Maruoka R; Ikeda A; Chiba T; Watanabe N
    J Gastroenterol Hepatol; 2013 Jun; 28(6):982-91. PubMed ID: 23425147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat.
    de Vos AF; Klaren VN; Kijlstra A
    Invest Ophthalmol Vis Sci; 1994 Oct; 35(11):3873-83. PubMed ID: 7928184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting interleukin-6 in autoimmune uveitis.
    Mesquida M; Molins B; Llorenç V; de la Maza MS; Adán A
    Autoimmun Rev; 2017 Oct; 16(10):1079-1089. PubMed ID: 28778705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements.
    Yu CR; Choi JK; Uche AN; Egwuagu CE
    J Leukoc Biol; 2018 Dec; 104(6):1147-1157. PubMed ID: 30117603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New biologic drugs: anti-interleukin therapy.
    Tappeiner C; Möller B; Hennig M; Heiligenhaus A
    Dev Ophthalmol; 2012; 51():79-89. PubMed ID: 22517206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis.
    Demir T; Gödekmerdan A; Balbaba M; Türkçüoglu P; Ilhan F; Demir N
    Indian J Ophthalmol; 2006 Dec; 54(4):241-5. PubMed ID: 17090875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Knowledge of Biologics in Treatment of Noninfectious Uveitis.
    Gupta S; Shyamsundar K; Agrawal M; Vichare N; Biswas J
    J Ocul Pharmacol Ther; 2022 Apr; 38(3):203-222. PubMed ID: 35133890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of IL-35 in inflammatory autoimmune diseases.
    Su LC; Liu XY; Huang AF; Xu WD
    Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-19 as a potential therapeutic in autoimmune and inflammatory diseases.
    Azuma YT; Nakajima H; Takeuchi T
    Curr Pharm Des; 2011 Nov; 17(34):3776-80. PubMed ID: 22103848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation.
    Greiner K; Murphy CC; Willermain F; Duncan L; Plskova J; Hale G; Isaacs JD; Forrester JV; Dick AD
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):170-6. PubMed ID: 14691170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Interleukin-32 in autoimmunity.
    de Albuquerque R; Komsi E; Starskaia I; Ullah U; Lahesmaa R
    Scand J Immunol; 2021 Feb; 93(2):e13012. PubMed ID: 33336406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings.
    Dinarello CA
    J Biol Regul Homeost Agents; 1997; 11(3):91-103. PubMed ID: 9498158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.